An in silico drug repurposing pipeline to identify drugs with the potential to inhibit SARS-CoV-2 replication-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An in silico drug repurposing pipeline to identify drugs with the potential to inhibit SARS-CoV-2 replication

Published:2023 Issue: Volume:43 Page:101387
ISSN:2352-9148
Container-title:Informatics in Medicine Unlocked
language:en
Short-container-title:Informatics in Medicine Unlocked

Author:

MacMahon Méabh^ORCID,Hwang Woochang,Yim Soorin,MacMahon Eoghan,Abraham Alexandre,Barton Justin,Tharmakulasingam Mukunthan,Bilokon Paul,Gaddi Vasanthi Priyadarshini,Han Namshik

Funder

LifeArc

National Research Foundation

Ministry of Science, ICT and Future Planning

Korea Ministry of Science and ICT

Publisher

Elsevier BV

Subject

Health Informatics

Reference119 articles.

1. COVID-19 map,2020

2. Anosmia and loss of smell in the era of covid-19;Walker;BMJ,2020

3. Mild or moderate covid-19;Gandhi;N Engl J Med,2020

4. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy;Jiang;Int J Biol Sci,2022

5. COVID-19: consider cytokine storm syndromes and immunosuppression;Mehta;Lancet Lond Engl,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP